State of New Jersey Common Pension Fund A’s Carisma Therapeutics CARM Stock Holding History

State of New Jersey Common Pension Fund A’s Portfolio CARM Stock Details CARM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	$1.22M	Buy	+3,750	New	+$1.12M	0.01%	728

Other funds holding CARM

TRV

Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return

FV2GP

Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

TCW Group Los Angeles, California $14.9B AUM 46.29% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return

State of New Jersey Common Pension Fund A's CARM Position: Q1 2014 in Review

State of New Jersey Common Pension Fund A opened a new position in Carisma Therapeutics (CARM) in Q1 2014: 3,750 shares worth $1.22M. The stake represents 0.01% of the portfolio and ranks #728 among its holdings.

32 funds tracked by Wall St. Rank hold CARM as of Q1 2014.

State of New Jersey Common Pension Fund A held 3,750 shares of Carisma Therapeutics worth $1.22M as of Q1 2014.
Carisma Therapeutics was a new State of New Jersey Common Pension Fund A position in Q1 2014.
Carisma Therapeutics made up 0.01% of State of New Jersey Common Pension Fund A's portfolio in Q1 2014, its #728 holding.
32 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q1 2014.

Based on State of New Jersey Common Pension Fund A's 13F filing for Q1 2014, filed 5 May 2014.